Lunai Bioworks (LNAI) Short-term Investments (2025)
Lunai Bioworks (LNAI) recorded quarterly Short-term Investments of $387851.0 in Q2 2025, down 45.39% quarter-over-quarter from $710281.0 in Q1 2025.
Lunai Bioworks (LNAI) Short-term Investments (2025) Analysis & Trends
Lunai Bioworks' Short-term Investments history runs 1 years deep, the most recent figure standing at $387851.0 for Q2 2025.
- In Q2 2025, Short-term Investments changed N/A year-over-year to $387851.0; the TTM figure through Jun 2025 stood at $387851.0 (changed N/A YoY), while the FY2025 annual figure was $387851.0, changed N/A from the prior year.
- Short-term Investments was $387851.0 for Q2 2025 at Lunai Bioworks, down from $710281.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $710281.0 in Q1 2025 to a low of $387851.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 387,851.00 |
| Mar 31, 2025 | 710,281.00 |